Weight & Adiposity
Reference materials for in-vitro and ex-vivo study of body-weight regulation, adipocyte biology, and fat-mass distribution.
For Research Use Only
This brief describes analytical reference materials supplied by R3TA LLC for in-vitro laboratory research. It is not a protocol and contains no dosing, administration, or therapeutic guidance. Not for human or animal consumption.
GLP-3 is a triple incretin-receptor agonist that has demonstrated dose-dependent reductions in body weight and adiposity in translational research models.
R3TA reference materials are supplied for in-vitro characterization of adipocyte differentiation, lipolysis, and energy-balance pathways—not as a weight-management agent.
All materials are released with identity and purity documentation and are intended For Research Use Only.
Representative in-vitro endpoints
- —3T3-L1 adipocyte differentiation and lipid-droplet quantification
- —cAMP accumulation in GLP-1R, GIPR, and GCGR transfected cell lines
- —Ex-vivo adipose-tissue explant lipolysis and thermogenesis markers
- —Body-composition surrogate endpoints in validated preclinical models
Handling & storage
- —Store lyophilized material at −20 °C, protected from light
- —Reconstitute with sterile diluent immediately before assay
- —Aliquot after reconstitution to avoid repeated freeze–thaw
- —Record lot number and reconstitution date in the laboratory record
Analytical documentation
- —Identity confirmed by LC-MS against theoretical monoisotopic mass
- —Purity determined by RP-HPLC at 214 nm
- —Endotoxin and residual solvent data available on request